Weight loss injections have become increasingly popular among adults and they’ve been proven to work. Now, there’s evidence that those drugs could be used to treat obesity in kids, as well.
Media Landscape
See how news outlets across the political spectrum are covering this story. Learn more
Left 37%
Center 52%
Right 11%
Bias Distribution Powered by Ground News™
Novo Nordisk tested its drug Saxenda on kids between 6 and 12 years old, and found that it helped them reach a healthier weight.
Like other weight loss drugs, Saxenda started as a drug used to treat type 2 diabetes under the name Victoza. However, it quickly became popular for its weight loss effects. Instead of using semaglutide, like Ozempic and Wegovy, or tirzepatide, like Zepbound and Mounjaro, Saxenda uses liraglutide.
Point phone camera here
Right now, the only options for treating childhood obesity are diet and exercise. Novo Nordisk is asking U.S. regulators to expand use of the medication to kids as young as 6.
Like the other weight loss drugs approved for adult use, Saxenda is an injection and the most common side effects are nausea, vomiting, and diarrhea. Also like with the other medications, stopping its use can cause kids to gain some weight back. Still, multiple experts say it’s a step in the direction of treating childhood obesity.
Lauren Taylor
WEIGHT LOSS INJECTIONS HAVE BECOME INCREASINGLY POPULAR AMONG ADULTS – AND THEY’VE BEEN PROVEN TO WORK.
NOW – THERE’S EVIDENCE THEY COULD BE USED TO TREAT OBESITY IN KIDS.
NOVO NORDISK TESTED ITS DRUG “SAXENDA” ON KIDS BETWEEN 6 AND 12 YEARS OLD… AND IT FOUND THAT IT HELPED THEM REACH A HEALTHIER WEIGHT.
LIKE THE OTHERS – SAXENDA STARTED AS A DRUG USED TO TREAT TYPE 2 DIABETES – UNDER THE NAME VICTOZA – BUT QUICKLY BECAME POPULAR FOR ITS WEIGHT LOSS EFFECTS.
INSTEAD OF USING SEMAGLUTIDE, LIKE OZEMPIC AND WEGOVY… OR TIRZEPATIDE (ter-ZEP-uh-tide), LIKE ZEPBOUND AND MOUNJARO (moon-JAR-o) – SAXENDA USES LIRAGLUTIDE (LIR-uh-GLOO-tide).
RIGHT NOW, THE ONLY OPTIONS FOR TREATING CHILDHOOD OBESITY ARE DIET AND EXERCISE… BUT NOVO NORDISK IS ASKING U-S REGULATORS TO EXPAND USE OF THE MEDICATION TO KIDS AS YOUNG AS 6.
LIKE THOSE OTHER WEIGHT LOSS DRUGS APPROVED FOR ADULT USE – SAXENDA IS An INJECTION AND THE MOST COMMON SIDE EFFECTS ARE NAUSEA, VOMITING, AND DIARRHEA.
AND ALSO LIKE WITH THE OTHER MEDICATIONS – STOPPING ITS USE CAN CAUSE KIDS TO GAIN SOME WEIGHT BACK.
STILL, MULTIPLE EXPERTS SAY IT’S A STEP IN THE DIRECTION OF TREATING CHILDHOOD OBESITY.
Media Landscape
See how news outlets across the political spectrum are covering this story. Learn more
Left 37%
Center 52%
Right 11%
Bias Summary
- Tellus fringilla ultricies litora risus pretium nisi aliquet suscipit egestas arcu aenean eu vel integer, pharetra lectus nisl consectetur taciti tempus tempor imperdiet ex feugiat praesent facilisi ac.
- Praesent ultrices ut sodales venenatis id dignissim diam iaculis euismod primis luctus, fusce nibh vestibulum etiam dictum tincidunt vivamus vitae in.
- Potenti luctus magnis ac orci mattis himenaeos diam, tincidunt per aenean at laoreet aliquam.
Bias Comparison
The Left
cras egestas facilisi augue placerat mi eu conubia fermentum, tristique id primis phasellus nisl per.
The Center
nisi commodo ullamcorper lacinia convallis amet aliquam, metus montes felis proin.
Report an issue with this comparison
Bias Distribution
43 other sources covering this story
Total News Sources
43
Leaning Left
10
Center
14
Leaning Right
3
Last Updated
7 months ago
Bias Distribution Powered by Ground News™
Straight to your inbox.
By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.
